Life After the Women's Health Initiative: Where Do We Stand?

Area of Science:

• Menopause Management
• Hormone Therapy Research
• Women's Health

Background:

• The Women's Health Initiative study led to a significant decrease in hormone replacement therapy (HRT) prescriptions.
• This decline left numerous women experiencing untreated menopausal symptoms, negatively impacting their quality of life.
• Current clinical practice requires a re-evaluation of HRT's role in managing menopausal symptoms.

Purpose of the Study:

• To summarize the established benefits and risks associated with hormone replacement therapy (HRT).
• To review current position statements from leading medical organizations regarding HRT use.
• To provide guidance on supporting shared decision-making for appropriate HRT application in menopausal symptom management.

Main Methods:

• Literature review of HRT benefits and risks.
• Analysis of position statements from major medical societies.
• Framework development for patient-clinician shared decision-making.

Main Results:

• HRT offers significant benefits for managing moderate to severe menopausal symptoms.
• Risks associated with HRT vary based on type, duration, and individual patient factors.
• Organizational guidelines emphasize individualized treatment approaches and shared decision-making.

Conclusions:

• Shared decision-making is crucial for determining HRT appropriateness in managing menopausal symptoms.
• A balanced understanding of HRT benefits and risks supports informed patient choices.
• Personalized HRT strategies can improve quality of life for women experiencing menopausal symptoms.